FDA NDC Directory · JSON-LD · Markdown
NDC 65162-339 · HUMAN PRESCRIPTION DRUG · GEL
| Labeler / Manufacturer | Amneal Pharmaceuticals LLC |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA209890 |
| Dosage form / route | GEL · TOPICAL |
| Active ingredients | DAPSONE (50 mg/g) |
| Marketing started | 20231024 |
| Package count | 3 |
Source: openFDA. Public-domain (CC0).